A nurse who fueled Ebola fears by flying to Cleveland after being infected by her dying patient was released Tuesday from a hospital isolation unit, where doctors defended her as a courageous front-line caregiver.
President Barack Obama moved Tuesday to alleviate growing concerns among healthcare workers that traveling to West Africa to help stem the Ebola outbreak at its source will land them under mandatory quarantine when they return.
The Centers for Disease Control and Prevention Monday issued new guidance for travelers returning to the U.S. from West Africa amid criticism over the measures some states have taken in implementing mandatory quarantines of returning healthcare workers.
The Centers for Disease Control and Prevention's current approach for handling the arrival of Ebola in the U.S. actually has its roots in the country's bioterrorism strategy from a decade ago.
The Ebola diagnosis last Thursday of Dr. Craig Spencer, a Doctors Without Borders physician who returned to the U.S. from Guinea earlier this month, set off mandatory quarantine orders in three states, and stricter monitoring in a fourth, Florida. The inevitable backlash against those quarantines...
Don't rush. Take your time. Be careful and deliberate. Federal officials repeated that guidance again and again last week as they reviewed their new, more-stringent Ebola-protection protocols before thousands of healthcare workers in New York City.
The U.S. healthcare system got a new Ebola patient last week when a doctor in New York City tested positive, while another, Texas nurse Nina Pham, was declared free of the Ebola virus.
Many are welcoming the Centers for Disease Control and Prevention's tighter safety guidelines for treating Ebola patients. But meeting those standards may pose financial challenges for hospitals.
The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.
The American public's deep fears about Ebola and U.S. politicians' inflammatory rhetoric following the three U.S. cases in Dallas have prompted public health experts to think about how the country might respond to a more serious infectious disease pandemic, and what lessons can be learned from the...
A few pharmaceutical and biotechnology manufacturers are evaluating the best ways to get their experimental Ebola drugs in the hands of doctors even as experts raise questions about the ethics and science behind using drugs that haven't gone through a randomized clinical trial.
Conceding its previous Ebola safety protocols failed in Dallas, the Centers for Disease Control and Prevention issued more robust guidelines aimed at better protecting workers who confront Ebola and other deadly infectious diseases.